Evidence map›Paper›PMID 38587441›Full record

ArticleInvestigative ophthalmology & visual science2024

Characterization of a Novel Mouse Model for Fuchs Endothelial Corneal Dystrophy.

Subashree Murugan, Viviane Souza de Campos, Sachin Anil Ghag, Matthew Ng, Rajalekshmy Shyam

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. METTL3-mCell death discovery · 2025
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Subashree MuruganVision Science Program, School of Optometry, Indiana University Bloomington, Indiana, United States.
Viviane Souza de CamposVision Science Program, School of Optometry, Indiana University Bloomington, Indiana, United States.
Sachin Anil GhagVision Science Program, School of Optometry, Indiana University Bloomington, Indiana, United States.
Matthew NgDepartment of Biology, Indiana University Bloomington, Indiana, United States.
Rajalekshmy ShyamVision Science Program, School of Optometry, Indiana University Bloomington, Indiana, United States.
Indiana University Bloomington · US

Funding

Molecular Dysregulation in Fuchs Corneal Endothelial DystrophyR00EY032974 · NEI · UNIVERSITY OF IOWA · PI SHYAM, RAJALEKSHMY · 2023 to 2025
$727k
NEI NIH HHS R00 EY032974
6 · The paper itself

Abstract

Purpose: Fuchs endothelial corneal dystrophy (FECD) is a progressive blinding disorder, characterized by increased corneal endothelial excrescences (guttae), corneal endothelial cell loss, and edema. These symptoms are hypothesized to be caused by changes in the extracellular matrix (ECM) and mitochondrial dysfunction in the corneal endothelium. Despite this clinical and biological relevance, a comprehensive animal model that recapitulates all the major disease characteristics is currently unavailable. In this study, we develop such a model to improve our understanding of the signaling pathways involved in the FECD progression and develop strategies for early intervention. Method: To generate a comprehensive FECD model, we generated a double mutant mouse bearing tamoxifen-inducible knockdown of Slc4a11 and the Col8a2 (Q455K) mutation. We performed optical coherence tomography (OCT) and in vivo confocal microscopy using the Heidelberg Retinal Tomography 3 - Rostock Cornea module (HRT3-RCM) on the mice at 5 weeks of age before tamoxifen feeding to establish baseline values for corneal thickness, endothelial cell density, and test for the presence of guttae. We measured these parameters again post-tamoxifen treatment at 16 weeks of age. We collected corneas at 16 weeks to perform histopathology, immunofluorescence staining for tight junctions, adherens junctions, and oxidative stress. We evaluated endothelial pump function using a lactate assay. Results: The double mutant tamoxifen-fed animals showed the presence of guttae, and displayed increased corneal thickness and decreased endothelial cell density. Endothelial cells showed altered morphology with disrupted adherens junctions and elevated reactive oxygen species (ROS). Finally, we found that stromal lactate concentrations were elevated in the double mutant mice, indicative of compromised endothelial pump function. Conclusions: Overall, this mouse model recapitulates all the important phenotypic features associated with FECD.

Indexed as

Fuchs' Endothelial DystrophySymportersAnimalsAnion Transport ProteinsDisease Models, AnimalEndothelial CellsLactic AcidMiceTamoxifenAnion Transport ProteinsLactic AcidSlc4a11 protein, mouseSymportersTamoxifen

Identifiers

PMID38587441
PMCPMC11005065
OpenAlexW4394579079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.